Sandoz Pharmaceuticals AG - Wyost 120 mg/ 1.7 ml, Injektionslösung
69944
01
Wyost 120 mg/ 1.7 ml
Injektionslösung
M05BX04
Denosumab
24.01.2025
Composition
denosumabum 120 mg, sorbitolum 78.9 mg, acidum aceticum glaciale, polysorbatum 20, natrii hydroxidum aut acidum hydrochloridum concentratum q.s. ad pH, aqua ad iniectabile q.s. ad solutionem pro 1.7 ml corresp. natrium 0.5 mg.
Packungsbestandteile
Solution injectable
Principe actif
Concentr.
Denosumabum
120 mg
Agents auxilliaires
Concentr.
Acidum Aceticum Glaciale
Natrii Hydroxidum aut Acidum Hydrochloridum Concentratum
